IKBKG and diabetic kidney disease: A Cell-permeable peptide, designing with the inhibitor of kappa B kinase γ (IKKγ)/NF-κB essential modulator (NEMO)-binding domain (NBD), alleviates the albuminuria, kidney damage, podocyte loss and GBM thickness in DKD rat models (Opazo-Rios et al., 2020).